Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | HH2710 |
Synonyms | |
Therapy Description |
HH2710 is an inhibitor of ERK1 (MAPK3) and ERK2 (MAPK1), which prevents cell proliferation (NCI Thesaurus). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
HH2710 | HH-2710|HH 2710 | ERK Inhibitor (pan) 21 | HH2710 is an inhibitor of ERK1 (MAPK3) and ERK2 (MAPK1), which prevents cell proliferation (NCI Thesaurus). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04198818 | Phase Ib/II | HH2710 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors | Terminated | USA | 1 |